Press Release Details

    Business Editors

    MELVILLE, N.Y.--(BUSINESS WIRE)--September 9, 1999--Henry Schein, Inc. (Nasdaq:HSIC) today announced that Michael Racioppi, Vice President and General Manager of the direct marketing Medical Division, has been named as interim President of Henry Schein's Medical Group. He succeeds Bruce J. Haber who has resigned effective immediately as President of Henry Schein's Medical Group in order to pursue other opportunities and personal interests. Mr. Haber has also resigned as a member of Henry Schein's Board of Directors.

Stanley M. Bergman, Chairman, Chief Executive Officer and President of Henry Schein, said, "Mike Racioppi has done an outstanding job in all of his responsibilities and most recently as head of our direct marketing medical business. In his seven years with Henry Schein, Mike has demonstrated the strong leadership and entrepreneurial skills that have made Henry Schein an industry leader."

Bruce Haber is to be thanked for his contributions in integrating Micro Bio-Medics into Henry Schein's medical business, and overall for his contribution to the Schein Medical Group. We wish him well in his future endeavors," Mr. Bergman added.

Michael Racioppi joined Henry Schein, Inc. in 1992 as Senior Director, Corporate Merchandising. In succeeding years, he was rapidly promoted to additional positions of responsibility in both corporate merchandising and marketing. He was appointed Vice President and General Manager of the direct marketing Medical Division in 1998. He holds a bachelor's degree from the University of Rhode Island and is a registered pharmacist.

Henry Schein, Inc. is the largest distributor of healthcare products and services to office-based healthcare practitioners, including dental practices and laboratories, physician practices and veterinary clinics. The Company, recognized for its excellent customer service and low prices, serves more than 300,000 customers worldwide. Headquartered in Melville, New York, the Company employs over 6,000 people in 16 countries. Sales in 1998 were $1.9 billion. For more information, visit the Henry Schein website at http://www.henryschein.com.

     --30--jc/ny*

     CONTACT: Henry Schein, Inc.
              Steven Paladino
              Senior Vice President and
              Chief Financial Officer
              (516) 843-5500
                   or 
              Susan Vassallo
              Manager, Investor and
              Public Relations
              516-843-5562
              svassa@henryschein.com

     KEYWORD: NEW YORK
     INDUSTRY KEYWORD: MEDICINE BIOTECHNOLOGY MANAGEMENT CHANGES